Skip to main content
Top

Pathology & Oncology Research

Issue 1/2005

Content (10 Articles)

Minireview

Genomics of lung cancer may change diagnosis, prognosis and therapy

László Kopper, József Tímár

Article

Polymorphisms of the XRCC1 DNA repair gene in head and neck cancer

Semra Demokan, Deniz Demir, Yusufhan Suoglu, Erkan Kiyak, Ugur Akar, Nejat Dalay

Article

Changes of cell adhesion and extracellular matrix (ECM) components in cervical intraepithelial neoplasia

Gábor Sobel, István Szabó, Csilla Páska, András Kiss, Ilona Kovalszky, Anna Kádár, Ferenc Paulin, Zsuzsa Schaff

Article

Immunohistochemical analysis of c-myc, c-jun and estrogen receptor in normal, hyperplastic and neoplastic endometrium

Sema Bircan, Arzu Ensari, Sibel Ozturk, Nural Erdogan, Ilkkan Dundar, Firat Ortac

Article

Is quadrant biopsy sufficient in men likely to have advanced prostate cancer? Comparison with extended biopsy

Zoran Brnic, Slavko Gašparov, Petar Vladislav Lozo, Petar Anic, Leonardo Patrlj, Vesna Ramljak

Article

Expression of p53, Ki-67 and Bcl-2 in parathyroid adenoma and residual normal tissue

Tuvia Hadar, Jacob Shvero, Eitan Yaniv, Eduard Ram, Itzhak Shvili, Rumelia Koren

Case Report

Familial cystic nephroma in two siblings with pleuropulmonary blastoma

Nebil Bal, Fazilet Kayaselçuk, Ayse Polat, Filiz Bolat, Zerrin Yilmaz, Ilhan Tuncer

Case Report

Cystic thymoma

Ralf J. Rieker, Sebastian Aulmann, Philipp A. Schnabel, Falk-Udo Sack, Herwart F. Otto, Gunhild Mechtersheimer, Peter Schirmacher, Hendrik Bläker

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine